Delivery Order SPE2DB22D3016-SPE2DB25FBDF1
- Not listed
- The U.S. Department of Defense's Medical Supply Chain awarded a $22,957.99 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Yervoy 200 mg/40 mL vials. This competitive award, with an ultimate completion date of August 19, 2025, represents a firm fixed-price contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location. Yervoy (ipilimumab) is an immunotherapy...
- The Defense Logistics Agency awarded a $114,789.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of YERVOY 200 mg/40 mL vials. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 28, 2025, and performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Yervoy 50 mg/10 ml vial (10 ml), a prescription medication, with a ceiling value of $22,870.92. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 7, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Yervoy 50 mg/10 ml vials, a specialized cancer medication. The contract has a ceiling value of $11,435.46 and a period of performance ending on May 29, 2025. The contract is a firm fixed-price, non-set-aside arrangement, indicating open competition. AmerisourceBergen Drug Corp...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Yervoy 50 mg/10 ml vials, a medication used for the treatment of certain types of cancer. The contract has a firm fixed price and a ceiling value of $22,870.92. It is a non-set-aside contract, indicating open competition. The contract has an ultimate completion date of May 6, 2025 and was awarded on April...
- This is a $11,435.46 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YERVOY 50 MG/10 ML VIAL 10ML pharmaceutical products, with a period of performance through July 3, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated...
- This is a $11,435.46 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of YERVOY 50 MG/10 ML VIAL 10ML, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of April 2, 2025 and was awarded on March 12, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract award, valued at $40,996.83, is for the supply of Yervoy 50 mg/10 ml vials. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563875830 YERVOY 50 MG/10 ML VIAL 10ML, a specialty pharmaceutical product. The delivery order has a potential value of $18,459.12 and a completion date of March 27, 2024. This order is placed under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $45,915.98, is for the supply of YERVOY 200 MG/40 ML VIAL 40ML, a specialty medication. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBDF1Delivery Order
The Defense Logistics Agency awarded a $25,022.41 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Yervoy 200 mg/40 mL vials. The contract represents a firm fixed-price delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to military healthcare programs worldwide. The delivery order is unclassified as a set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. Yervoy (ipilimumab) is an immunotherapy medication used in cancer treatment, reflecting DLA's procurement of specialized oncology pharmaceuticals for military medical systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical supply contracts with the Defense Logistics Agency and serves critical roles in supporting Defense Health Agency and military healthcare operations. This delivery order exemplifies the company's established capability to provide competitively awarded pharmaceutical products across multiple therapeutic domains to federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.0k | 7/28/25 |